Back to Discover

MiniMed Group, Inc. stock: filings, catalysts and timeline

MMED · Biotech · Nasdaq · As of 4 Nov 2026

Sign in to follow

58AIR SCORE
  • FundamentalsWhat is this?Not scored — outside AIR's $300M–$20B fundamentals band

    How the business is doing on its own reported US-GAAP numbers — growth, margins, cash generation, balance-sheet strength, capital efficiency and dilution — compared with sector peers.

    Source: SEC XBRL financial statements.

  • ValueWhat is this?Too few of the required measures on file

    How the shares are priced against sector peers, against the company's own recent history, and against a simple cash-flow estimate, using the filing numbers and the current price. AIR shows this as a band, never as a target price.

    Source: SEC XBRL financial statements and end-of-day prices.

  • News flowWhat is this?Balanced

    What the company has documented recently: material 8-K events (contracts, deals, results, leadership changes) and FDA approvals, weighted by recency and type. A language model's reading of each 8-K helps classify whether it is positive or negative. Filings, not press or social media.

    Source: SEC EDGAR 8-K filings and FDA approvals.

  • MomentumWhat is this?Balanced

    The longer-term market read: the trend in end-of-day prices, strength against the market and the sector, and trading volume over roughly the past three to twelve months. It is shown, never used to rank the Shortlist.

    Source: End-of-day prices.

  • SafetyWhat is this?Strong

    The risk side: leverage, liquidity, cash runway, dilution, revenue and margin swings, company size and pre-commercial status, negative 8-K events (including legal and regulatory ones), and share-price drawdown and volatility. Higher means fewer of those risk markers.

    Source: SEC XBRL financial statements, SEC EDGAR 8-K filings and end-of-day prices.

How AIR scores →

Discovery Gap: Very high (71/100) · Gap confidence 57/100

Very high71
DISCOVERY GAP

Documented progress is running well ahead of market attention.

Low is the most common level — the cut-offs are fixed, and levels can shift as scores refresh.

What is this?

How far documented progress (News flow) runs ahead of market attention. Attention is measured from institutional holdings reported to the SEC, trading volume, price behaviour and how richly the shares are valued — not from social media or analyst ratings.

Source: SEC EDGAR filings (8-K and 13F), FDA approvals and end-of-day prices.

How levels work. The levels use fixed cut-offs, but market attention is ranked against the other ~1,800 companies AIR covers that day (valuation against the same sector). Documented progress counts filings from the past 18 months, newer ones weighing more; attention uses the latest quarter of institutional holdings, the last three to six months of trading, and six to twelve months of price behaviour. Many companies show a Low Gap or none at all — a gap needs filings that read more positively than neutral. A level can change from one day to the next as scores refresh and the other companies move.

  • Gap confidenceWhat is this?Moderate 57/100How fully AIR could measure this Gap.

    How fully AIR could measure both sides of the Discovery Gap: the documented progress (News flow) and market attention (Recognition). It takes the weaker of the two, and reads zero when either side has no measurement. It describes the data, not the company.

  • Evidence strengthWhat is this?Moderate 34/100Support behind the full AIR read, not only the Gap.

    How much data stands behind the whole AIR read — all five perspectives, not just the Discovery Gap. Each perspective reports how complete its inputs are, and these are combined in the same proportions as the AIR Score; a perspective AIR could not score adds nothing, so missing data lowers this figure. It describes the data, not the company.

This month at a glance

AIR Score™ change: +5Moved up +5 on new evidence.
Window31 Oct 2026 → 4 Nov 2026
Momentum+5Lifted the score this month.

Evidence timeline

  1. Expected
  2. Mon 19 Apr · expected 10-Q

    Last year filed 17 Apr 2026.

  3. Tue 29 Jun · expected 10-K

    Last year filed 29 Jun 2026.

  4. Filed
  5. Fri 16 Oct · 8-K

    8-K · Items 5.01, 5.02 — Change in control

    MiniMed completed its separation from Medtronic on October 15, 2026, becoming a fully independent company. Medtronic exchanged 55.0M ordinary shares for 252.8M MiniMed shares, eliminating Medtronic's equity stake. Exchange offer was 5.4x subscribed.

    News flow: Balanced 53 → Balanced 57Recognition: Balanced 52 → Balanced 59Gap Very high · 57 → Very high · 82

    The filings read more positively.

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

  6. Tue 13 Oct · 8-K

    8-K filed 2026-10-13

    Recognition: Balanced 56 → Balanced 53

    Market attention has faded.

    The price trend weakened.

  7. Tue 8 Sep · 10-Q

    Quarterly report (10-Q), period ending 31 Jul 2026

  8. Tue 1 Sep · 8-K

    8-K · Item 2.02 — Results of operations

  9. Wed 5 Aug · 8-K

    8-K · Item 5.02 — Director or officer change

  10. Mon 29 Jun · 10-K

    Annual report (10-K), FY2026

  11. Mon 29 Jun · 8-K

    8-K · Items 5.02, 8.01 — Director or officer change

  12. Wed 3 Jun · 8-K

    8-K · Item 2.02 — Results of operations

  13. Mon 18 May · 8-K

    8-K · Item 5.02 — Director or officer change

  14. Mon 27 Apr · 8-K

    8-K filed 2026-04-27

  15. Fri 17 Apr · 10-Q

    Quarterly report (10-Q), period ending 11 Apr 2026

  16. Fri 27 Mar · 8-K

    8-K · Item 5.02 — Director or officer change

  17. Wed 25 Mar · 8-K

    8-K filed 2026-03-25

  18. Mon 9 Mar · 8-K

    8-K · Items 1.01, 2.01, 2.03, 3.02, 3.03, 5.02 — Material agreement

Solid dots: a filing AIR classified as material. Grey: routine. Hollow: expected, from last year's dates — not a forecast.

Ask AIR

What would change our view

A weaker balance sheet in the next filing cycle, a material regulatory setback, or attention arriving — which closes the gap by design would move the score, and the page would show which one did.

Research, not tips. No buy/sell recommendations, no price forecasts. Every score is derived from public filings and market data — figures round to whole numbers and refresh each trading day.